Home Cart 0 Sign in  

[ CAS No. 69-33-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 69-33-0
Chemical Structure| 69-33-0
Structure of 69-33-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 69-33-0 ]

Related Doc. of [ 69-33-0 ]

Alternatived Products of [ 69-33-0 ]

Product Details of [ 69-33-0 ]

CAS No. :69-33-0 MDL No. :MFCD00056012
Formula : C11H14N4O4 Boiling Point : -
Linear Structure Formula :- InChI Key :HDZZVAMISRMYHH-KCGFPETGSA-N
M.W : 266.25 Pubchem ID :6245
Synonyms :
7-Deazaadenosine;7-DZA;U 10071;Tubercidine;TBC;Sparsomycin A;SKI 26996;B 120121;Antibiotic XK 101-1;NSC 56408
Chemical Name :4-Amino-7-(β-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidine

Calculated chemistry of [ 69-33-0 ]

Physicochemical Properties

Num. heavy atoms : 19
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.45
Num. rotatable bonds : 2
Num. H-bond acceptors : 6.0
Num. H-bond donors : 4.0
Molar Refractivity : 64.88
TPSA : 126.65 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -8.71 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.2
Log Po/w (XLOGP3) : -1.1
Log Po/w (WLOGP) : -1.69
Log Po/w (MLOGP) : -1.65
Log Po/w (SILICOS-IT) : -1.87
Consensus Log Po/w : -1.02

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.02
Solubility : 25.6 mg/ml ; 0.0963 mol/l
Class : Very soluble
Log S (Ali) : -1.07
Solubility : 22.7 mg/ml ; 0.0852 mol/l
Class : Very soluble
Log S (SILICOS-IT) : 0.04
Solubility : 289.0 mg/ml ; 1.09 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 3.73

Safety of [ 69-33-0 ]

Signal Word:Danger Class:6.1
Precautionary Statements:P264-P301+P310 UN#:3462
Hazard Statements:H300 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 69-33-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 69-33-0 ]
  • Downstream synthetic route of [ 69-33-0 ]

[ 69-33-0 ] Synthesis Path-Upstream   1~15

  • 1
  • [ 16754-80-6 ]
  • [ 69-33-0 ]
Reference: [1] Helvetica Chimica Acta, 1988, vol. 71, # 6, p. 1573 - 1585
[2] Tetrahedron Letters, 1987, vol. 28, # 43, p. 5107 - 5110
[3] Journal of Heterocyclic Chemistry, 1988, vol. 25, # 6, p. 1893 - 1898
[4] Patent: WO2018/133854, 2018, A1, . Location in patent: Paragraph 0191; 0198; 0199
[5] Patent: WO2018/156625, 2018, A1, . Location in patent: Paragraph 0278
  • 2
  • [ 24386-93-4 ]
  • [ 69-33-0 ]
Reference: [1] Journal of Organic Chemistry, 2018, vol. 83, # 15, p. 8589 - 8595
[2] Bioorganic and Medicinal Chemistry, 2017, vol. 25, # 20, p. 5433 - 5440
  • 3
  • [ 120401-34-5 ]
  • [ 69-33-0 ]
Reference: [1] Helvetica Chimica Acta, 1988, vol. 71, # 6, p. 1573 - 1585
  • 4
  • [ 29914-75-8 ]
  • [ 69-33-0 ]
Reference: [1] Journal of Organic Chemistry, 2018, vol. 83, # 15, p. 8589 - 8595
  • 5
  • [ 102690-94-8 ]
  • [ 69-33-0 ]
Reference: [1] Helvetica Chimica Acta, 1988, vol. 71, # 6, p. 1573 - 1585
[2] Helvetica Chimica Acta, 1988, vol. 71, # 6, p. 1573 - 1585
[3] Journal of Heterocyclic Chemistry, 1988, vol. 25, # 6, p. 1893 - 1898
[4] Tetrahedron Letters, 1987, vol. 28, # 43, p. 5107 - 5110
  • 6
  • [ 94773-30-5 ]
  • [ 69-33-0 ]
Reference: [1] Liebigs Annalen der Chemie, 1984, # 12, p. 1972 - 1980
  • 7
  • [ 21193-80-6 ]
  • [ 69-33-0 ]
Reference: [1] Journal of Organic Chemistry, 2018, vol. 83, # 15, p. 8589 - 8595
  • 8
  • [ 75921-20-9 ]
  • [ 69-33-0 ]
Reference: [1] Helvetica Chimica Acta, 1988, vol. 71, # 6, p. 1573 - 1585
[2] Helvetica Chimica Acta, 1988, vol. 71, # 6, p. 1573 - 1585
  • 9
  • [ 115479-39-5 ]
  • [ 69-33-0 ]
Reference: [1] Helvetica Chimica Acta, 1988, vol. 71, # 6, p. 1573 - 1585
[2] Journal of Heterocyclic Chemistry, 1988, vol. 25, # 6, p. 1893 - 1898
[3] Tetrahedron Letters, 1987, vol. 28, # 43, p. 5107 - 5110
  • 10
  • [ 85572-94-7 ]
  • [ 69-33-0 ]
Reference: [1] Liebigs Annalen der Chemie, 1984, # 12, p. 1972 - 1980
  • 11
  • [ 3680-69-1 ]
  • [ 69-33-0 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1988, vol. 25, # 6, p. 1893 - 1898
[2] Tetrahedron Letters, 1987, vol. 28, # 43, p. 5107 - 5110
  • 12
  • [ 120401-29-8 ]
  • [ 69-33-0 ]
Reference: [1] Helvetica Chimica Acta, 1988, vol. 71, # 6, p. 1573 - 1585
  • 13
  • [ 16754-86-2 ]
  • [ 69-33-0 ]
Reference: [1] Helvetica Chimica Acta, 1988, vol. 71, # 6, p. 1573 - 1585
  • 14
  • [ 85335-76-8 ]
  • [ 69-33-0 ]
  • [ 90813-69-7 ]
  • [ 64526-34-7 ]
Reference: [1] Tetrahedron, 1984, vol. 40, # 1, p. 125 - 135
  • 15
  • [ 69-33-0 ]
  • [ 1500-85-2 ]
  • [ 72933-38-1 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 2: Physical Organic Chemistry (1972-1999), 1986, p. 525 - 530
Same Skeleton Products
Historical Records